Aurisco Pharmaceutical (605116.SH): Tian Tai Bo En plans to reduce its shareholding by no more than 0.25%.

Aurisco Pharmaceutical (605116.SH) announced that, in response to the financial needs of some of its partners, within 3 months after 15 trading days from the day of the announcement (excluding the window period), TianTai Platinum plans to reduce its holdings of the company's shares by no more than 1 million shares, or 0.25% of the total issued shares of the company, through centralized bidding and block trading methods.